Fig. 5From: Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinomaKaplan-Meier plots of TTR (upper row) and OS (lower row) according to treatment (surgery only vs. neoadjuvant chemotherapy NOS ± adjuvant chemotherapy NOS) in patients with: (a, c) PODXL negative tumors, or (b, d) PODXL positive tumorsBack to article page